• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 20-F filed by Burcon NutraScience Corp.

    8/1/22 4:22:18 PM ET
    $BRCN
    Other Metals and Minerals
    Basic Materials
    Get the next $BRCN alert in real time by email
    Burcon NutraScience Corporation: Form 20-F - Filed by newsfilecorp.com
    0001158399 FY false


    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    FORM 20-F

    [ ]  REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OFTHE SECURITIES EXCHANGE ACT OF 1934

    OR

    [x]  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For the fiscal year ended March 31, 2022

    OR

    [ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    OR

    [ ]   SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    Date of event requiring this shell company report ................................................... 

    For the transition period from .................................... to ....................................

    Commission file number 001-35289

    Burcon NutraScience Corporation

    (Exact name of Registrant as specified in its charter)

    British Columbia, Canada

    (Jurisdiction of incorporation or organization)

    1946 West Broadway 

    Vancouver, British Columbia, Canada V6J 1Z2

    (Address of principal executive offices)

    Jade Cheng,

    Telephone: (604) 733-0896

    Facsimile: (604) 733-8821

    1946 West Broadway 

    Vancouver, British Columbia, Canada V6J 1Z2

    (Name, telephone, email and/or facsimile number and address of Company Contact Person)

    Securities registered or to be registered pursuant to Section 12(b) of the Act:


    1


         

    Title of Class

    Trading Symbol(s)

    Name of Each Exchange on Which Registered

    Common Shares, no par value

    BRCN

    Nasdaq Capital Market

    Securities registered or to be registered pursuant to Section 12(g) of the Act: None

    Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None

    Indicate the number of outstanding shares of each of the issuer's classes of capital or stock as of the closing of the period covered by the annual report:

    108,728,742 Common shares

    Indicate by check mark if the registration is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

    [  ] Yes [X] No

    If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

    [  ] Yes [X] No

    Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days

    [X] Yes [  ] No

    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

    [X] Yes [  ] No

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, and/or an emerging growth company. See definition of "large accelerated filer," "accelerated filer," and "emerging growth company" in Rule 12b-2 of the Exchange Act:

    Large accelerated filer [  ] Accelerated filer [  ] Non-accelerated filer [X]

    Emerging growth company [ ]

    If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. [  ]

    † The term "new or revised financial accounting standard" refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.


    2


    Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

    [ ]

    Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

    U.S. GAAP [  ]

    International Financial Reporting Standards as issued by the International Accounting Standards Board [X]

    Other [  ]

    If "Other" has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow

    Item 17 [  ] Item 18 [  ]

    If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

    [  ] Yes [X] No


    3


    ANNUAL INFORMATION FORM, AUDITED ANNUAL CONSOLIDATED

    FINANCIAL STATEMENTS AND MANAGEMENT'S DISCUSSION AND ANALYSIS

    Annual Information Form

    The Registrant's Annual Information Form for the fiscal year ended March 31, 2022 is attached as Exhibit 99.1 to this Annual Report on Form 20-F and is incorporated herein by reference.

    Audited Annual Consolidated Financial Statements

    The Registrant's audited annual consolidated financial statements for the fiscal year ended March 31, 2022, including the report of the independent registered public accounting firm (PCAOB #271) with respect thereto, are attached as Exhibit 99.2 to this Annual Report on Form 20-F and are incorporated herein by reference.

    We have determined that our equity method investment in Merit Functional Foods Corporation (“Merit”), which is not consolidated in our financial statements, was significant under the income test of Rule 1-02(w) of Regulation S-X in relation to our consolidated financial results for the year ended March 31, 2022.  The consolidated financial statements of Merit as of and for the year ended December 31, 2021 as required under by Rule 3-09 of Regulation S-X (“Rule 3-09”) have not been presented as they cannot be provided without unreasonable effort or expense.

    We requested that the staff of the U.S. Securities and Exchange Commission (the “SEC”) grant relief from the financial statement filing requirements of Rule 3-09 pursuant to Section 2430 of the Division of Corporation Finance Financial Reporting Manual, with respect to our investment in Merit. The SEC has not granted our company’s waiver request and, as a result, our company was required to file with the SEC separate audited financial statements for Merit. However, it has been impracticable for our company to comply with this requirement, because  the audit of Merit’s financial statements was completed in accordance with Canadian generally accepted auditing standards and do not meet the requirements for filing with the Form 20-F annual report.  We do not have the contractual right to re-audit the Merit financial statements in accordance with United States generally accepted auditing standards. We believe that Merit’s financial statements would not provide additional material information to investors. However, we cannot assure you that that the SEC will not take actions against our company relating to our non-compliance, and, among other matters, we may be delisted from Nasdaq due to failure to file Merit’s financial statements with the Form 20-F, or in the event of a capital raise, our company may be temporarily unable to have a registration statement for a public offering of securities in the United States declared effective by the SEC.  For more information, see Exhibit 99.5 Item 3.D. Key Information —Risk Factors—Our inability to provide audited financial statements for Merit in accordance with Rule 3-09 may result in enforcement actions by the SEC or may, among other matters, cause us to be unable to complete a public offering in the United States.” For more information on Merit, see notes 2 and 7 to our audited annual consolidated financial statements included in this annual report.

    Management's Discussion and Analysis

    The Registrant's Management's Discussion and Analysis for the fiscal year ended March 31, 2022 is attached as Exhibit 99.3 to this Annual Report on Form 20-F and is incorporated herein by reference.

    Notice of Annual Meeting and Management Proxy Circular

    The Registrant's Notice of Annual Meeting and Management Proxy Circular for the fiscal year ended March 31, 2022 is attached as Exhibit 99.4 to this Annual Report on Form 20-F and is incorporated herein by reference.

    Additional Information

    An Additional Information document is attached as Exhibit 99.5 to this Annual Report on Form 20-F and is incorporated herein by reference.

    Cross Reference to Form 20-F

    Item No.   Exhibit Pages
    Part I      
    Item 1 Identity of Directors, Senior Management and Advisers N/A N/A
    Item 2 Offer Statistics and Expected Timetable N/A N/A
    Item 3 Key Information    
      A. [Reserved] N/A N/A
      B. Capitalization and indebtedness N/A N/A
      C. Reasons for the offer and use of proceeds N/A N/A
      D. Risk factors 99.1 51-59
        99.3 30-32
        99.5 1
    Item 4 Information on the Company    
      A. History and development of the company 99.1 Cover page, 5-20, 91

    4


        99.3 4
      B. Business overview 99.1 16-51
        99.3 4-17
      C. Organizational structure 99.1 5
        99.2 2
      D. Property, plants and equipment 99.1 32, 37-38, 41-42
        99.2 11
        99.5 1
    Item 4A Unresolved Staff Comments N/A N/A
    Item 5 Operating and Financial Review and Prospects    
      A. Operating results 99.1 5-16
        99.3 19-22
      B. Liquidity and capital resources 99.2 30
        99.3 22-23
      C. Research and development, patents and licenses, etc. 99.1 32, 34-37
        99.3 20-21
      D. Trend information 99.1 38-41
      E. Critical Accounting Estimates 99.2 4.5
        99.3 27-28
           
    Item 6 Directors, Senior Management and Employees    
      A. Directors and senior management 99.1 64-77
        99.3 12
        99.4 5-10,19
      B. Compensation 99.4 34-47
      C. Board practices 99.1 64-69, 89-91, Schedule "A"
        99.4 5-7, 24-27
           
      D. Employees 99.1 38
      E. Share Ownership 99.1 64-69
        99.4 6-7,13-18, 29-32, 34-38, 44-47
    Item 7 Major Shareholders and Related Party Transactions    
      A. Major shareholders 99.4 1,6, 44-47
        99.5 1
      B. Related party transactions 99.1 6-7, 14, 76-77, 78
        99.2 25-26
        99.3 26-27
        99.4 48
      C. Interests of experts and counsel N/A N/A
     

    5


     
    Item No.   Exhibit Pages
    Item 8 Financial Information    
      A. Consolidated Statements and Other Financial Information 99.1 60
        99.2 All
        99.3 All
      B. Significant changes 99.2 32-33
    Item 9 The Offer and Listing    
      A. Offer and listing details 99.1 6, 60
           
      B. Plan of distribution N/A N/A
      C. Markets 99.1 6, 60
      D. Selling shareholders N/A N/A
      E. Dilution N/A N/A
      F. Expenses of the issue N/A N/A
    Item 10 Additional Information    
      A. Share Capital N/A N/A
      B. Memorandum and articles of association 99.5 2-6
      C. Material contracts 99.1 78-89
      D. Exchange controls N/A N/A
      E. Taxation 99.5 6-13
      F. Dividends and paying agents N/A N/A
      G. Statement by experts N/A N/A
      H. Documents on display 99.1 91
        99.3 1
        99.4 48
      I. Subsidiary information N/A N/A
      J. Annual Report to Security Holders    
    Item 11 Quantitative and Qualitative Disclosures About Market Risk 99.2 29-31
        99.3 23-25
    Item 12 Description of Securities Other than Equity Securities N/A N/A
           
    Part II      
    Item 13 Defaults, Dividend Arrearages and Delinquencies N/A N/A
    Item 14 Material Modifications to the Rights of Security Holders and Use of Proceeds N/A N/A
    Item 15 Controls and Procedures 99.3 29-30
        99.5 13-14
     

    6


     
    Item 16 [Reserved]    
    Item 16A. Audit committee financial expert 99.1 89-90
    Item 16B. Code of Ethics 99.4 21, Schedule "B"
    Item 16C. Principal Accountant Fees and Services 99.1 89-91
    Item 16D. Exemptions from the Listing Standards for Audit Committees N/A N/A
    Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers N/A N/A
    Item 16F. Change in Registrant's Certifying Accountant N/A N/A
    Item 16G. Corporate Governance 99.5 14
    Item 16H. Mine Safety Disclosure N/A N/A
    Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections N/A N/A
     
    Item No.   Exhibit Pages
    Part III      
    Item 17 Financial Statements N/A N/A
    Item 18 Financial Statements 99.2 All
         

    See “Audited Annual Consolidated Financial Statements” on page  1 hereof

    Item 19 Exhibits Exhibit Index Exhibit Index
     

    7


    SIGNATURES

    The Registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and has duly caused and authorized the undersigned to sight this Annual Report on its behalf.

        BURCON NUTRASCIENCE CORPORATION
         
    Date: August 1, 2022 By: /s/ Peter H. Kappel
        Name: Peter H. Kappel
        Title: Interim Chief Executive Officer
     

    8


    EXHIBIT INDEX

     
    1.1 Articles of Incorporation of Burcon NutraScience Corporation, dated September 25, 2020 (filed as Exhibit 99.48 to the registration statement on Form 40-F filed on May 17, 2021 and incorporated herein by reference).
       
    2.1 Description of Securities
       
    4.1 Repayable Contribution Agreement dated effective February 24, 2020 for the Agriinnovate Program dated between Her Majesty the Queen in Right of Canada, Merit Functional Foods Corporation, 11410083 Canada Ltd., Burcon NutraScience Holdings Corp., RBT Holdco Ltd. and 10039406 Manitoba Ltd. (filed as Exhibit 99.24 to the registration statement on Form 40-F filed on May 17, 2021 and incorporated herein by reference).
       
    4.2 Termination of License and Production Agreement dated August 7, 2020 between Burcon NutraScience Corporation and Burcon NutraScience (MB) Corp. and Archer-Daniels-Midland Company (filed as Exhibit 99.25 to the registration statement on Form 40-F filed on May 17, 2021 and incorporated herein by reference).
       
    4.3 Amended and Restated Unanimous Shareholders Agreement dated August 27, 2020 among Burcon NutraScience Holdings Corp., Tirem Holdings Inc., Merit Functional Foods Corporation and Tirem Holdings Limited Partnership, by its general partner Tirem Holdings GP Inc., Burcon NutraScience Corporation (filed as Exhibit 99.29 to the registration statement on Form 40-F filed on May 17, 2021 and incorporated herein by reference).
       
    4.4 Amended and Restated License and Production Agreement dated August 27, 2020 between Burcon NutraScience Corporation, Burcon NutraScience (MB) Corp. and Merit Functional Foods Corporation (filed as Exhibit 99.30 to the registration statement on Form 40-F filed on May 17, 2021 and incorporated herein by reference).
       
    4.5 Reciprocal Indemnity Agreement dated October 8, 2021 among Burcon NutraScience Holdings Corp. and certain shareholders of RBT Holdco Ltd. and 10039406 Manitoba Ltd. (filed as Exhibit 99.1 to the Form 6-K filed on June 27, 2022 and incorporated herein by reference).
       
    4.6 Amended and Restated Reciprocal Indemnity Agreement dated January 12, 2022 among Burcon NutraScience Holdings Corp. and certain shareholders of RBT Holdco Ltd. and 10039406 Manitoba Ltd. (filed as Exhibit 99.2 to the Form 6-K filed on June 27, 2022 and incorporated herein by reference).
       
    4.7 Senior Secured Loan Agreement dated June 20, 2022 between Burcon NutraScience Corporation and Large Scale Investments Limited (filed as Exhibit 99.2 to the Form 6-K filed on June 29, 2022 and incorporated herein by reference).
       
    8 List of Subsidiaries (see "Intercorporate Relationships" on page 5 of the Annual Information Form for the fiscal year ended March 31, 2022 filed hereto as Exhibit 99.1.)
       
    11 Code of Business Ethics and Conduct (included as Schedule "B" to the Notice of Annual Meeting and Management Proxy Circular for the fiscal year ended March 31, 2022, filed hereto as Exhibit 99.4).
     

    9


    12.1 Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934.
       
    12.2 Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934.
       
    13.1 Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
       
    13.2 Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
       
    99.1 Annual Information Form for the fiscal year ended March 31, 2022.
       
    99.2 Audited Annual Consolidated Financial Statements for the fiscal year ended March 31, 2022.
       
    99.3 Management's Discussion and Analysis for the fiscal year ended March 31, 2022.
       
    99.4 Notice of Annual Meeting and Management Proxy Circular for the fiscal year ended March 31, 2022.
       
    99.5 Additional Information.
       
    101.INS Inline XBRL Instance Document–the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document
       
    101.SCH Inline XBRL Taxonomy Extension Schema Document
       
    101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
       
    101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
       
    101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
       
    101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
       
    104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

    10


    Get the next $BRCN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BRCN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BRCN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Burcon Issues Shareholder Letter

    Vancouver, British Columbia--(Newsfile Corp. - September 6, 2022) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BRCN) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, today issued a letter to shareholders from its Interim CEO and Chairman of the Board, Peter H. Kappel.Dear Fellow Shareholders,This past Friday we announced the resignation of our Auditor of the past 21 years, PricewaterhouseCoopers LLP ("PwC"). This must have come as a surprise to you, as it did us when we were informed by PwC their intention to resign. What was particularly agonizing for us was their insistence on the immediacy of carrying throu

    9/6/22 8:00:00 AM ET
    $BRCN
    Other Metals and Minerals
    Basic Materials

    Burcon Announces Delisting from Nasdaq Capital Market

    Vancouver, British Columbia--(Newsfile Corp. - September 2, 2022) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BRCN) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, today announced that it intends to file a Form 25 (Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934) with the Securities and Exchange Commission (the "SEC") on September 12, 2022 to delist the Company's common shares from the Nasdaq Capital Market and to deregister its common shares under Section 12(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The comm

    9/2/22 4:00:33 PM ET
    $BRCN
    Other Metals and Minerals
    Basic Materials

    Burcon Announces Auditor Resignation and AGM Postponement

    Vancouver, British Columbia--(Newsfile Corp. - September 2, 2022) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BRCN) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, today announced the resignation of its auditors, PricewaterhouseCoopers LLP ("PwC"), effective September 1, 2022 and that it is postponing its annual meeting of shareholders (the "AGM"), which was to be held on September 14, 2022.PwC has confirmed that there have been no "reportable events", "disagreements" or "unresolved issues" (as such terms are defined in National Instrument 51-102 - Continuous Disclosure Obligations). Due to the inopportune tim

    9/2/22 4:00:00 PM ET
    $BRCN
    Other Metals and Minerals
    Basic Materials

    $BRCN
    SEC Filings

    View All

    SEC Form 6-K filed by Burcon NutraScience Corp.

    6-K - Burcon NutraScience Corp (0001158399) (Filer)

    8/28/23 2:51:39 PM ET
    $BRCN
    Other Metals and Minerals
    Basic Materials

    SEC Form D filed by Burcon NutraScience Corp.

    D - Burcon NutraScience Corp (0001158399) (Filer)

    5/23/23 3:54:43 PM ET
    $BRCN
    Other Metals and Minerals
    Basic Materials

    SEC Form 25 filed by Burcon NutraScience Corp.

    25 - Burcon NutraScience Corp (0001158399) (Filer)

    9/12/22 8:35:06 AM ET
    $BRCN
    Other Metals and Minerals
    Basic Materials

    $BRCN
    Leadership Updates

    Live Leadership Updates

    View All

    Burcon Issues Shareholder Letter

    Vancouver, British Columbia--(Newsfile Corp. - September 6, 2022) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BRCN) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, today issued a letter to shareholders from its Interim CEO and Chairman of the Board, Peter H. Kappel.Dear Fellow Shareholders,This past Friday we announced the resignation of our Auditor of the past 21 years, PricewaterhouseCoopers LLP ("PwC"). This must have come as a surprise to you, as it did us when we were informed by PwC their intention to resign. What was particularly agonizing for us was their insistence on the immediacy of carrying throu

    9/6/22 8:00:00 AM ET
    $BRCN
    Other Metals and Minerals
    Basic Materials

    Burcon Announces Auditor Resignation and AGM Postponement

    Vancouver, British Columbia--(Newsfile Corp. - September 2, 2022) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BRCN) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, today announced the resignation of its auditors, PricewaterhouseCoopers LLP ("PwC"), effective September 1, 2022 and that it is postponing its annual meeting of shareholders (the "AGM"), which was to be held on September 14, 2022.PwC has confirmed that there have been no "reportable events", "disagreements" or "unresolved issues" (as such terms are defined in National Instrument 51-102 - Continuous Disclosure Obligations). Due to the inopportune tim

    9/2/22 4:00:00 PM ET
    $BRCN
    Other Metals and Minerals
    Basic Materials

    Burcon Announces Appointment of Peter H. Kappel as Interim CEO

    Vancouver, British Columbia--(Newsfile Corp. - March 1, 2022) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BRCN) ("Burcon or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce that Peter H. Kappel, Chairman of Burcon's board of directors, will assume the role of interim Chief Executive Officer ("CEO"), with immediate effect, until a successor is appointed by the Company's board of directors.Mr. Kappel is a former investment banker who served in senior roles at Nomura, Dresdner Kleinwort Wasserstein, Calyon and DVB Bank in London. He brings extensive experience in strategic and business management as well

    3/1/22 8:00:00 AM ET
    $BRCN
    Other Metals and Minerals
    Basic Materials

    $BRCN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Burcon NutraScience Corp.

    SC 13G - Burcon NutraScience Corp (0001158399) (Subject)

    2/14/24 12:39:37 PM ET
    $BRCN
    Other Metals and Minerals
    Basic Materials

    SEC Form SC 13G filed by Burcon NutraScience Corp.

    SC 13G - Burcon NutraScience Corp (0001158399) (Subject)

    1/26/22 9:42:58 AM ET
    $BRCN
    Other Metals and Minerals
    Basic Materials

    $BRCN
    Financials

    Live finance-specific insights

    View All

    Burcon Reports Fiscal 2023 First Quarter Results

    Vancouver, British Columbia--(Newsfile Corp. - August 15, 2022) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BRCN) ("Burcon or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, reported results for the fiscal first quarter ended June 30, 2022.Operational highlights for the first quarter ended June 30, 2022:During the quarter, Burcon:recorded a 17% quarter-over-quarter increase in royalty revenues from its licensee, Merit Functional Foods Corporation ("Merit");provided a $3.16 million loan to Merit, as part of a $10 million funding contributed by shareholders in proportion to their Merit shareholding;advanced the due diligence

    8/15/22 4:07:00 PM ET
    $BRCN
    Other Metals and Minerals
    Basic Materials

    Burcon Announces Fiscal 2023 First Quarter Conference Call to be Held on August 15, 2022

    Vancouver, British Columbia--(Newsfile Corp. - August 2, 2022) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BRCN) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, will hold an investor conference call and webcast on Monday, August 15, 2022 at 5:00 p.m. Eastern time to discuss its financial results for the fiscal first quarter ended June 30, 2022. The Company's financial results will be issued in a press release prior to the call.A link to the webcast of the conference call will be available on Burcon's website under "Presentations" or directly here. The webcast will also be archived for future playback.Investo

    8/2/22 8:00:00 AM ET
    $BRCN
    Other Metals and Minerals
    Basic Materials

    Burcon Announces Fiscal 2022 Results and Reviews Operations

    Vancouver, British Columbia--(Newsfile Corp. - June 27, 2022) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BRCN) ("Burcon or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, reported results for the fiscal year ended March 31, 2022."Fiscal 2022 was a year in which we saw the successful commercialization of Burcon's pea and canola protein technologies, establishing our joint venture and licensee, Merit Functional Foods, as the world's first and only commercial producer of food-grade canola protein ingredients," said Peter H. Kappel, Burcon's interim CEO and Chairman of the board, adding, "Merit reached a significant milestone

    6/27/22 4:08:00 PM ET
    $BRCN
    Other Metals and Minerals
    Basic Materials